-
FDA approves Mylan hypertension drug
SILVER SPRING, Md. — The Food and Drug Administration has approved a drug for treating high blood pressure made by Mylan, FDA records showed.
The FDA approved Mylan's metoprolol succinate tablets in the 25-mg, 50-mg, 100-mg and 200-mg strengths.
The drug is a generic version of AstraZeneca's Toprol-XL.
-
ERSP challenges stem cell claims made by online marketer Emergent Health
NEW YORK — The Electronic Retailing Self-Regulation Program on Wednesday recommended that Emergent Health modify or discontinue certain Internet advertising claims for the company’s “JDI MultiVitamin,” promoted by the advertiser as designed to “increase adult stem cells.” The marketer voluntarily modified several claims at issue in ERSP’s inquiry.